Literature DB >> 6612369

Radiology of medullary chondrosarcoma: preoperative treatment planning.

T M Hudson, B J Manaster, D S Springfield, S S Spanier, W F Enneking, I F Hawkins.   

Abstract

We evaluated the radiologic studies of 30 medullary chondrosarcomas with respect to their accuracy in diagnosis and surgical staging. There were 30 sets of plain radiographs, 14 conventional tomograms, 26 radionuclide bone scans, 19 arteriograms, and 15 computed tomograms (CT). Plain radiographs provided most of the diagnostic information although many tumours looked benign. CT provided the most complete anatomic staging, including intra- and extraosseous tumor, and neurovascular involvement. However, it was difficult to be sure about subtle soft tissue invasion. Arteriography remained useful for evaluating major vessel involvement or cortical penetration when CT and conventional tomography were equivocal. Scintigrams disclosed increased uptake, usually corresponding to the true tumor extent; "extended uptake" beyond the tumor was uncommon. Conventional tomography has been largely replaced by CT, but was occasionally useful when the tumor was near the end of a bone.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6612369     DOI: 10.1007/bf00360788

Source DB:  PubMed          Journal:  Skeletal Radiol        ISSN: 0364-2348            Impact factor:   2.199


  21 in total

1.  CARTILAGE TUMOURS.

Authors:  J H MIDDLEMISS
Journal:  Br J Radiol       Date:  1964-04       Impact factor: 3.039

2.  The value of arteriography in the diagnosis of bone tumours.

Authors:  B STRICKLAND
Journal:  Br J Radiol       Date:  1959-11       Impact factor: 3.039

3.  The blood vessels of chondrosarcomas.

Authors:  C LAGERGREN; A LINDBOM; G SODERBERG
Journal:  Acta radiol       Date:  1961-05       Impact factor: 1.990

4.  Prognostic factors in chondrosarcoma of bone: a clinicopathologic analysis with emphasis on histologic grading.

Authors:  H L Evans; A G Ayala; M M Romsdahl
Journal:  Cancer       Date:  1977-08       Impact factor: 6.860

5.  Priscoline in bone and soft-tissue angiography.

Authors:  I F Hawkins; T Hudson
Journal:  Radiology       Date:  1974-03       Impact factor: 11.105

6.  Central chondrosarcoma of the appendicular skeleton.

Authors:  F B Reiter; L V Ackerman; T W Staple
Journal:  Radiology       Date:  1972-12       Impact factor: 11.105

7.  The value of angiography in planning surgical treatment of bone tumors.

Authors:  T M Hudson; W F Enneking; I F Hawkins
Journal:  Radiology       Date:  1981-02       Impact factor: 11.105

8.  Numerical assessment of bone scintigraphy in primary bone tumors and tumor-like conditions.

Authors:  O Sneppen; J Heerfordt; I Dissing; M Jensen; J Møller; M Nørbjerg
Journal:  J Bone Joint Surg Am       Date:  1978-10       Impact factor: 5.284

9.  Radiological evaluation of chondroblastoma.

Authors:  T M Hudson; I F Hawkins
Journal:  Radiology       Date:  1981-04       Impact factor: 11.105

10.  Radionuclide bone scanning of medullary chondrosarcoma.

Authors:  T M Hudson; F S Chew; B J Manaster
Journal:  AJR Am J Roentgenol       Date:  1982-12       Impact factor: 3.959

View more
  3 in total

1.  Case report 470. Conventional chondrosarcoma of the left fibula.

Authors:  H J Schneider; A S Weinstein
Journal:  Skeletal Radiol       Date:  1988       Impact factor: 2.199

2.  Diagnostic value of MRI-based 3D texture analysis for tissue characterisation and discrimination of low-grade chondrosarcoma from enchondroma: a pilot study.

Authors:  Catharina S Lisson; Christoph G Lisson; Kerstin Flosdorf; Regine Mayer-Steinacker; Markus Schultheiss; Alexandra von Baer; Thomas F E Barth; Ambros J Beer; Matthias Baumhauer; Reinhard Meier; Meinrad Beer; Stefan A Schmidt
Journal:  Eur Radiol       Date:  2017-09-07       Impact factor: 5.315

3.  Magnetic resonance imaging of primary tumours and tumour-like lesions of bone.

Authors:  K Bohndorf; M Reiser; B Lochner; W Féaux de Lacroix; W Steinbrich
Journal:  Skeletal Radiol       Date:  1986       Impact factor: 2.199

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.